miércoles, 5 de junio de 2019

'Anchoring' was at work in setting the price of Zolgensma - STAT

'Anchoring' was at work in setting the price of Zolgensma - STAT

Daily Recap

Opinion: ‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy

By PETER B. BACH


ADOBE
In the U.S., drugs are priced at what the market will bear. A concept known as anchoring helped prime us for the $2.1 million price tag for Zolgensma.

No hay comentarios: